Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

被引：124
|
作者：
Pinheiro, Ruben G. R. [1 ]
Coutinho, Ana Joyce [1 ]
Pinheiro, Marina [1 ]
Neves, Ana Rute [1 ,2 ]
机构：
[1] Univ Porto, LAQV, REQUIMTE, Dept Ciencias Quim,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
[2] Univ Madeira, CQM Ctr Quim Madeira, Campus Penteada, P-9020105 Funchal, Portugal
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 21期
关键词：
Alzheimer's disease; drug delivery; drug targeting; neurodegenerative diseases; Parkinson's disease; SOLID LIPID NANOPARTICLES; PEG-PLA NANOPARTICLES; NICOTINIC ACETYLCHOLINE-RECEPTORS; IIB-IIIA COMPLEX; PLGA NANOPARTICLES; IN-VITRO; LOADED NANOPARTICLES; GLUCOSE TRANSPORTERS; TRANSFERRIN-RECEPTOR; TUMOR VASCULATURE;
D O I：
10.3390/ijms222111654
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The blood-brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the brain and target the desired anatomic region. The use of nanomedicine has great potential to overcome this problem, since one can modify nanoparticles with strategic molecules that can interact with the BBB and induce uptake through the brain endothelial cells and consequently reach the brain tissue. This review addresses the potential of nanomedicines to treat neurological diseases by using nanoparticles specially developed to cross the BBB.
引用
收藏
页数：22
相关论文
共 50 条
  • [21] Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E
    Neves, Ana Rute
    Queiroz, Joana Fontes
    Weksler, Babette
    Romero, Ignacio A.
    Couraud, Pierre-Olivier
    Reis, Salette
    NANOTECHNOLOGY, 2015, 26 (49)
  • [22] Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
    Elena Puris
    Gert Fricker
    Mikko Gynther
    Pharmaceutical Research, 2022, 39 : 1415 - 1455
  • [23] Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?
    Mandelblatt, Jeanne S.
    Hurria, Arti
    McDonald, Brenna C.
    Saykin, Andrew J.
    Stern, Robert A.
    Van Meter, John W.
    McGuckin, Meghan
    Traina, Tiffani
    Denduluri, Neelima
    Turner, Scott
    Howard, Darlene
    Jacobsen, Paul B.
    Ahles, Tim
    SEMINARS IN ONCOLOGY, 2013, 40 (06) : 709 - 725
  • [24] Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery
    Torres-Perez, Sergio Andres
    Torres-Perez, Cindy Estefani
    Pedraza-Escalona, Martha
    Perez-Tapia, Sonia Mayra
    Ramon-Gallegos, Eva
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Peptide Targeted Lipid Nanoparticles for Anticancer Drug Delivery
    Pearce, Timothy R.
    Shroff, Kamlesh
    Kokkoli, Efrosini
    ADVANCED MATERIALS, 2012, 24 (28) : 3803 - 3822
  • [26] Outstanding Questions in Mitophagy: What We Do and Do Not Know
    Montava-Garriga, Lambert
    Ganley, Ian G.
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (01) : 206 - 230
  • [27] Lifestyle and cognition. What do we know from the aging and neurodegenerative brain?
    Steiner, B.
    Witte, V.
    Floeel, A.
    NERVENARZT, 2011, 82 (12): : 1566 - +
  • [28] Polymeric Nanoparticles for Brain Drug Delivery - A Review
    Raman, Subashini
    Mahmood, Syed
    Hilles, Ayah R.
    Javed, Md Noushad
    Azmana, Motia
    Al-Japairai, Khater Ahmed Saeed
    CURRENT DRUG METABOLISM, 2020, 21 (09) : 649 - 660
  • [29] Surfactant chain length effects on nanoparticles of biodegradable polymers for targeted drug delivery
    Liu, Yutao
    Feng, Si-Shen
    AICHE JOURNAL, 2012, 58 (11) : 3289 - 3297
  • [30] Surface-modified polycaprolactone nanoparticles for the brain-targeted delivery of nevirapine
    Lahkar, Sunita
    Das, Malay Kumar
    JOURNAL OF NANOPARTICLE RESEARCH, 2020, 22 (05)
12345